InVision | News

InVision Announces Adoption of New CPT Billing Code for InVision Precision Cardiac Amyloid by the American Medical Association

July 2, 2024

InVision receives U.S. FDA Clearance for Precision LVEF

May 14, 2024

InVision receives U.S. FDA Breakthrough Device Designation for its Cardiac Amyloidosis Algorithm

January 5, 2024

InVision enters artificial intelligence collaboration with Alexion to explore potential to improve detection of cardiac amyloidosis

November 16, 2023